Epirubicin in patients with inoperable non-small cell lung cancer--a phase II study

Acta Oncol. 1991;30(7):869-70. doi: 10.3109/02841869109091838.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Drug Evaluation
  • Epirubicin / adverse effects
  • Epirubicin / therapeutic use*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged

Substances

  • Epirubicin